Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POST II: Fludrocortisone for Vasovagal Syncope
NCT00118482Phase 4Completed
- Sponsor
- University of Calgary
- Start
- May 2005
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised trial in vasovagal syncope comparing fludrocortisone acetate with Placebo (2 arms). Primary endpoint: Recurrence of Syncope at 12 months. Started May 2005; status: completed.
02
Drugs
fludrocortisone
03
Conditions
vasovagal syncope
Beyond the preview
Go deeper on NCT00118482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118482.